Arteriosclerosis Thrombosis and Vascular Biology

732.2k citations
10.2k papers · · active since 1950

Impact in

Papers in

Arteriosclerosis Thrombosis and Vascular Biology

8.0k papers receiving 605.3k citations

Peers

Arteriosclerosis Thrombosis and Vascular Biology
Comparison fields: 5 of 235
  • Cardiology and Cardiovascular Medicine 117.0k
  • Immunology 113.5k
  • Internal Medicine 15.5k
  • Cancer Research 66.5k
  • Endocrinology, Diabetes and Metabolism 72.8k
Replace Atherosclerosis with:
Atherosclerosis United States
Circulation Research United States
Kidney International United States
Stroke United States
Biochemical Journal United Kingdom
The FASEB Journal United States
Clinical Chemistry United States
British Journal of Pharmacology United Kingdom
American Journal of Physiology-Heart and Circulatory Physiology United States
Cardiovascular Research United States
Arteriosclerosis Thrombosis and Vascular Biology relative to Atherosclerosis United States Atherosclerosis's profile →
Citations per field
00.5×4.0×
Atherosclerosis · 1×
Citations per year

Countries where authors publish in Arteriosclerosis Thrombosis and Vascular Biology

Since Specialization
Citations

This map shows the geographic impact of research published in Arteriosclerosis Thrombosis and Vascular Biology. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Arteriosclerosis Thrombosis and Vascular Biology with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arteriosclerosis Thrombosis and Vascular Biology more than expected).

Fields of papers published in Arteriosclerosis Thrombosis and Vascular Biology

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Arteriosclerosis Thrombosis and Vascular Biology. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Arteriosclerosis Thrombosis and Vascular Biology.

About Arteriosclerosis Thrombosis and Vascular Biology

The 10.2k papers published in Arteriosclerosis Thrombosis and Vascular Biology in the last decades have received a total of 732.2k indexed citations . Papers published in Arteriosclerosis Thrombosis and Vascular Biology usually cover Immunology and Allergy (452 papers), Hematology (848 papers), Cardiology and Cardiovascular Medicine (1.5k papers), Cancer Research (904 papers) and Immunology (1.3k papers) specifically the topics of Atherosclerosis and Cardiovascular Diseases (798 papers), Lipoproteins and Cardiovascular Health (653 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (562 papers), Cholesterol and Lipid Metabolism (518 papers), Blood Coagulation and Thrombosis Mechanisms (516 papers), Cell Adhesion Molecules Research (449 papers), Protease and Inhibitor Mechanisms (405 papers) and Adipokines, Inflammation, and Metabolic Diseases (402 papers). The most active scholars publishing in Arteriosclerosis Thrombosis and Vascular Biology are Peter Libby, Garret A. FitzGerald, Nigel Mackman, Renu Virmani, Ira Tabas, Scott M. Grundy, Emanuela Ricciotti, Frank D. Kolodgie, Göran K. Hansson and Alan Daugherty.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact